October 9, 11 AM Eastern/8 AM Pacific
View this email in your browser ([link removed])
Join PRI for an important webinar discussing the potential for biosimilars reform to save patients and taxpayers.
Register now to watch live on Wednesday at 11 AM Eastern/8 AM Pacific
[link removed]
PRI Webinar: The Biosimilar Promise: How Biosimilars Reform Could Save Patients and Taxpayers Even More
Wednesday, October 9
11 AM Eastern / 8 AM Pacific
* Click here ([link removed]) to register to attend the webinar via Zoom (registration required to attend)
Low-cost biosimilars generated $19 billion in savings value in today’s dollars in 2023. But obstacles in the current drug pricing system meant that billions of dollars in potential savings were left unrealized.
Join the Pacific Research Institute’s Center for Medical Economics and Innovation and panel of experts for a brief, informative webinar discussing how potential reforms can improve competition, generate more savings, and better serve patients and taxpayers. Ask your questions of the experts following their presentations.
[link removed]
ABOUT THE SPEAKERS
Conrad Bhamani
Manager
IQVIA Institute for Human Data Science
Conrad Bhamani is a Manager at the IQVIA Institute for Human Data Science. His key areas of interest include healthcare policy, U.S. market access, and economic modeling. Conrad has authored or contributed to multiple reports on long-term infused biosimilar sustainability, the Inflation Reduction Act of 2022, and other areas of U.S. healthcare policy. He previously worked in IQVIA’s Market Access and Strategy Consulting group; prior to joining IQVIA, he worked as an oncology researcher at Harvard Medical School / Massachusetts General Hospital.
------------------------------------------------------------
Craig Burton
Senior VP of Policy and Strategic Alliances, Assn. for Accessible Medicines; Executive Director, Biosimilars Council
Craig Burton is the Senior Vice President of Policy and Strategic Alliances for the Association for Accessible Medicines and the Executive Director of the Biosimilars Council. In his current role, Craig is responsible for leading policy development and issues management for AAM, directing the Biosimilars Council, and building relationships with strategic partners in the health care sector, including patient advocacy groups.
------------------------------------------------------------
Dr. Wayne Winegarden
Director, Center for Medical Economics and Innovation, Pacific Research Institute
Wayne Winegarden, Ph.D., is a Sr. Fellow in Business & Economics, Pacific Research Institute, as well as the Director of PRI’s Center for Medical Economics and Innovation. Dr. Winegarden’s policy research explores the connection between macroeconomic policies and economic outcomes, with a focus on fiscal policy, the health care industry, and the energy sector. As Director of the Center for Medical Economics and Innovation, Dr. Winegarden spearheads research and advances policies that support the continued viability and vitality of the U.S. biomedical and pharmaceutical industries to the benefit of patients and overall economic growth.
[link removed]
============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Instagram ([link removed])
** Website ([link removed])
Copyright © 2024 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116
** ([link removed])
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
